Position in PCVX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$29,189,102
+$1,614,402 QoQ
Shares Held
502,135
+5.8% QoQ
Ownership
0.337%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 329 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. PCVX ranks #32 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in PCVX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,189,102 | 502,135 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $27,574,700 | 474,526 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $20,733,605 | 449,363 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $15,834,820 | 439,612 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $14,619,548 | 449,694 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $15,784,204 | 418,014 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $34,539,841 | 421,938 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $47,084,950 | 412,050 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $35,382,396 | 468,579 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $28,179,578 | 412,525 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $25,064,544 | 399,117 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $20,189,656 | 396,031 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $19,059,895 | 381,656 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $11,283,202 | 301,046 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $14,751,720 | 307,648 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $4,309,680 | 179,570 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,396,234 | 156,077 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,679,590 | 152,364 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $3,460,801 | 145,473 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,490,860 | 137,598 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,667,569 | 118,506 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,675,530 | 84,837 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,752,025 | 65,940 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,617,879 | 53,015 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||